Examining the Potential Price Growth of Johnson & Johnson (JNJ)

Johnson & Johnson’s recently made public that its EVP, Global Corp Affairs Broadhurst Vanessa unloaded Company’s shares for reported $1.44 million on Mar 13 ’24. In the deal valued at $162.16 per share,8,891 shares were sold. As a result of this transaction, Broadhurst Vanessa now holds 15,043 shares worth roughly $2.24 million. Then, JOHNSON & […]

Negative sentiment towards JNJ reflected in surge in short interest

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Johnson & Johnson shares valued at $1,441,765 were sold by Broadhurst Vanessa on Mar 13 ’24. At $162.16 per share, Broadhurst Vanessa sold 8,891 shares. The insider’s holdings dropped to 15,043 […]

Examining the Potential Price Growth of Johnson & Johnson (JNJ)

Johnson & Johnson’s filing revealed that its EVP, Global Corp Affairs Broadhurst Vanessa unloaded Company’s shares for reported $1.44 million on Mar 13 ’24. In the deal valued at $162.16 per share,8,891 shares were sold. As a result of this transaction, Broadhurst Vanessa now holds 15,043 shares worth roughly $2.28 million. Then, JOHNSON & JOHNSON […]

Johnson & Johnson [JNJ] Stock sold by Insider Broadhurst Vanessa for $1.44 million

Johnson & Johnson’s recent filing unveils that its EVP, Global Corp Affairs Broadhurst Vanessa unloaded Company’s shares for reported $1.44 million on Mar 13 ’24. In the deal valued at $162.16 per share,8,891 shares were sold. As a result of this transaction, Broadhurst Vanessa now holds 15,043 shares worth roughly $2.37 million. Then, JOHNSON & […]

Investing in Johnson & Johnson (JNJ) Is Getting More Attractive

In a filing, Johnson & Johnson revealed its EVP, Global Corp Affairs Broadhurst Vanessa unloaded Company’s shares for reported $1.44 million on Mar 13 ’24. In the deal valued at $162.16 per share,8,891 shares were sold. As a result of this transaction, Broadhurst Vanessa now holds 15,043 shares worth roughly $2.33 million. Then, JOHNSON & […]

Fundamentally Strong, Technicals Not Yet Positive: Novavax Inc. (NVAX)

On June 14, Novavax Inc. (NVAX), a biotechnology company, announced that its NVX-CoV2373 vaccine achieved 90.4% effectiveness in the third phase of the clinical trial against Coronavirus. Furthermore, this drug is 100% protective against moderate to severe diseases. Novavax plans to apply for FDA approval by the third quarter of this year. There will be […]

Johnson & Johnson will soon begin shipping vaccines against Covid-19 to Europe: JNJ Stock

Johnson & Johnson (JNJ) announced that it would start shipping the vaccine against Covid-19 to Europe beginning April 19. Following Pfizer-BioNTech, Moderna and AstraZeneca, it was the fourth vaccine to receive approval by the European Medicines Agency in mid-March. Only the United States and South Africa are currently using the JNJ Covid-19 vaccine, although Canada […]